FLSM
TYRA icon

Frazier Life Sciences Management’s Tyra Biosciences TYRA Stock Holding History

Frazier Life Sciences Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-731,020
Closed -$17.2M – 55
2024
Q3 		$17.2M Sell
731,020
-101,200
-12% -$2.12M 0.69% 31
2024
Q2 		$13.3M Hold
832,220
– – 0.62% 33
2024
Q1 		$13.6M Sell
832,220
-194,200
-19% -$3.19M 0.58% 37
2023
Q4 		$14.2M Sell
1,026,420
-1,593
-0.2% -$20.6K 0.76% 35
2023
Q3 		$14.2M Hold
1,028,013
– – 0.94% 27
2023
Q2 		$17.5M Sell
1,028,013
-393,297
-28% -$5.7M 1.05% 24
2023
Q1 		$22.8M Buy
1,421,310
+93,645
+7% +$1.11M 1.65% 15
2022
Q4 		$10.1M Hold
1,327,665
– – 0.63% 31
2022
Q3 		$11.7M Sell
1,327,665
-47,400
-3% -$434K 0.9% 26
2022
Q2 		$9.83M Buy
1,375,065
+47,400
+4% +$377K 0.93% 29
2022
Q1 		$14.2M Buy
+1,327,665
New +$15.8M 1.21% 30

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Frazier Life Sciences Management's TYRA Position: Q4 2024 in Review

Frazier Life Sciences Management sold out of Tyra Biosciences (TYRA) in Q4 2024, closing a stake of 731,020 shares — an estimated $17.2M sold.

Frazier Life Sciences Management first reported a position in TYRA in Q1 2022 and held it in 11 quarters. The position peaked at $22.8M in Q1 2023. 113 funds tracked by Wall St. Rank hold TYRA as of Q4 2024.

  • Frazier Life Sciences Management reported no remaining Tyra Biosciences position as of Q4 2024 after selling out during the quarter.
  • Frazier Life Sciences Management sold 731,020 Tyra Biosciences shares in Q4 2024, an estimated $17.2M.
  • Frazier Life Sciences Management first reported a position in Tyra Biosciences in Q1 2022 and held it in 11 quarters.
  • Frazier Life Sciences Management's Tyra Biosciences position peaked at $22.8M in Q1 2023.
  • 113 funds tracked by Wall St. Rank held Tyra Biosciences as of Q4 2024.

Based on Frazier Life Sciences Management's 13F filing for Q4 2024, filed 18 Feb 2025.